The Metabolic Syndrome Pharmacology and Clinical Aspects /

Metabolic syndrome is a common syndrome affecting about 20% of the adult population in Europe, and the prevalence is likely similar in other industrialised countries worldwide. It is mainly caused by the western lifestyle, which tends to produce abdominal obesity, but a genetic predisposition also p...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Beck-Nielsen, Henning (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Vienna : Springer Vienna : Imprint: Springer, 2013.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 02210nam a22004695i 4500
001 978-3-7091-1331-8
003 DE-He213
005 20151125201012.0
007 cr nn 008mamaa
008 130326s2013 au | s |||| 0|eng d
020 |a 9783709113318  |9 978-3-7091-1331-8 
024 7 |a 10.1007/978-3-7091-1331-8  |2 doi 
040 |d GrThAP 
050 4 |a RC627.5-632 
072 7 |a MFGM  |2 bicssc 
072 7 |a MED027000  |2 bisacsh 
082 0 4 |a 616.39  |2 23 
245 1 4 |a The Metabolic Syndrome  |h [electronic resource] :  |b Pharmacology and Clinical Aspects /  |c edited by Henning Beck-Nielsen. 
264 1 |a Vienna :  |b Springer Vienna :  |b Imprint: Springer,  |c 2013. 
300 |a XI, 229 p.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
520 |a Metabolic syndrome is a common syndrome affecting about 20% of the adult population in Europe, and the prevalence is likely similar in other industrialised countries worldwide. It is mainly caused by the western lifestyle, which tends to produce abdominal obesity, but a genetic predisposition also plays a part. This syndrome, which is linked to leisure lifestyles and overeating/obesity, can develop into type 2 diabetes, cardiovascular disease and cancer. Therefore, proper treatment and prevention are essential. This book discusses lifestyle intervention and treatment, specifically with pharmacological compounds, in order to formulate a strategy for treating the metabolic syndrome in daily practice. 
650 0 |a Medicine. 
650 0 |a Pharmacology. 
650 0 |a Diabetes. 
650 0 |a Endocrinology. 
650 0 |a Metabolic diseases. 
650 1 4 |a Medicine & Public Health. 
650 2 4 |a Metabolic Diseases. 
650 2 4 |a Pharmacology/Toxicology. 
650 2 4 |a Endocrinology. 
650 2 4 |a Diabetes. 
700 1 |a Beck-Nielsen, Henning.  |e editor. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9783709113301 
856 4 0 |u http://dx.doi.org/10.1007/978-3-7091-1331-8  |z Full Text via HEAL-Link 
912 |a ZDB-2-SME 
950 |a Medicine (Springer-11650)